Most Read Articles
Rachel Soon, Yesterday

Gels utilizing Stichopus horrens (golden sea cucumber/gamat) extract show a similar efficacy to standard-of-care hydrogels for promoting wound healing, according to a prospective study.

Jairia Dela Cruz, 3 days ago
Use of mirabegron in the treatment of men with overactive bladder (OAB) appears to effectively alleviate urgency and storage symptoms, but not reduce the frequency of micturition episodes, according to data from the MIRACLE study.
5 days ago
Drinking coffee confers benefits for recurrence of hepatocellular carcinoma (HCC) and survival following orthotopic liver transplantation, a study has found.
6 days ago
A recent study has shown that the short-term efficacy of tenofovir disoproxil fumarate (TDF) is superior to entecavir (ETV) for the treatment of acute-on-chronic-liver failure (ACLF) due to reactivation of chronic hepatitis B (CHB).

Marijuana a promising treatment alternative for lower urinary tract symptoms

10 Sep 2018

Regular exposure to tetrahydrocannabinol (THC), an active component of cannabis, appears to have a protective effect on lower urinary tract symptoms (LUTS) in men, according to data from the National Health and Nutrition Examination Survey (NHANES).

Researchers identified 3,037 men aged 20–59 years from the NHANES database, all of whom completed urinary and substance abuse questionnaires. Of the men, 477 (14.72 percent) reported regular marijuana use (smoking at least once per month), and 1,668 (54.92 percent) reported at least one urinary symptom (nocturia, hesitancy, incomplete emptying or incontinence).

Relative to nonusers, regular THC users were more likely to have a normal body mass index (42.2 percent vs 23.8 percent; p<0.0001) and less likely to have diabetes (1.8 percent vs 5.7 percent; p=0.0014). Meanwhile, men with LUTS were more likely to be obese (38.1 percent vs 27.1 percent; p<0.0001) and have diabetes (8.2 percent vs 1.6 percent; p=0.0014) compared with those who did not have the condition.

Notably, men who reported regular THC use vs nonuse were less likely to have any single urinary symptom (40.1 percent vs 57.9 percent; p<0.0001) and to exhibit LUTS. Multivariable logistic regression analysis revealed that regular THC use was strongly associated with a 45-percent lower odds of reporting LUTS (odds ratio, 0.55; 95 percent CI, 0.408–0.751; p<0.01).

Significant independent predictors of LUTS included obesity, diabetes and multiple comorbidities (p<0.0001 for all).

The present data provide insight into a possible novel alternative therapy in men with LUTS, researchers said. Further prospective randomized controlled trials are warranted to validate the findings, determine the safety profile and clarify the role of THC in LUTS treatment.
Editor's Recommendations
Most Read Articles
Rachel Soon, Yesterday

Gels utilizing Stichopus horrens (golden sea cucumber/gamat) extract show a similar efficacy to standard-of-care hydrogels for promoting wound healing, according to a prospective study.

Jairia Dela Cruz, 3 days ago
Use of mirabegron in the treatment of men with overactive bladder (OAB) appears to effectively alleviate urgency and storage symptoms, but not reduce the frequency of micturition episodes, according to data from the MIRACLE study.
5 days ago
Drinking coffee confers benefits for recurrence of hepatocellular carcinoma (HCC) and survival following orthotopic liver transplantation, a study has found.
6 days ago
A recent study has shown that the short-term efficacy of tenofovir disoproxil fumarate (TDF) is superior to entecavir (ETV) for the treatment of acute-on-chronic-liver failure (ACLF) due to reactivation of chronic hepatitis B (CHB).